Author | country | Sample | MedAE | AE ≤ 0.5D | AE ≤ 1D |
---|---|---|---|---|---|
Dawson [8] | USA | 47 eyes (31 patients) | True-K (0.50), intraoperative aberrometry (0.48) | True-K (51.1%), intraoperative aberrometry (55.3%) | True-K (80.8%), intraoperative aberrometry (80.8%) |
Leite [13] | Brazil | 108 eyes | NR | Haigis (43.5%), True-K (42.6%) | Haigis (65.7%), True-K (75.9%) |
Turnbull [9] | Australia | 52 eyes (34 patients) | TKH (0.275), TKPH (0.382), TKNH (0.330), Haigis (0.406), Holladay (0.504), Haigis [-0.50 offset] (0.569), Potvin-Hill (0.632) | TKH (76.6%), TKPH (75.0%), TKNH (69.2%), Haigis (69.2%), Holladay (50.0%), Haigis [-0.50 offset] (46.2%), Potvin-Hill (40.4%) | TKH (97.9%), TKPH (95.8%), TKNH (92.3%), Haigis (92.3%), Holladay (84.6%), Haigis [-0.50 offset] (82.7%), Potvin-Hill (69.2%) |
Patel [10] | India | 54 eyes (36 patients) | NR | Atlas 1–4 (19.44%), IOLMaster (22.22%), True-K (22.22%), average IOL power (27.78%), minimum IOL power (22.22%), maximum IOL power (22.22%) | Atlas 1–4 (47.22%), IOLMaster (50.00%), True-K (50.00%), average IOL power (58.33%), minimum IOL power (52.78%), maximum IOL power (50.00%) |
Curado [11] | Brazil | 52 eyes (34 patients) | True-K (0.34), ORA (0.53), SRK/T (0.54), Hoffer Q (0.51), Haigis (0.54), Holladay 1 (0.57), Holladay 2 (0.44) | True-K (63.5%), ORA (48.1%), SRK/T (44.2%), Hoffer Q (48.1%), Haigis (53.8%), Holladay 1 (36.5%), Holladay 2 (57.7%) | True-K (88.5%), ORA (80.7%), SRK/T (76.9%), Hoffer Q (84.6%), Haigis (75.0%), Holladay 1 (76.9%), Holladay 2 (84.6%) |
Wang [14] | USA | 44 eyes (32 patients) | Haigis (0.47), True-K (0.55), Haigis-TK (0.57) | Haigis (54.5%), True-K (43.2%), Haigis-TK (43.2%) | Haigis (75.0%), True-K (70.5%), Haigis-TK (72.7%) |
This study | China | 47 eyes (28 patients) | True-K (0.62), Holladay 1 (D–K) (1.16), Haigis (0.76) | True-K (46.8%), Holladay 1 (D–K) (19.1%), Haigis (34.0%) | True-K (68.1%), Holladay 1 (D–K) (40.4%), Haigis (70.2%) |